News & Events

Read QuantuMDx’s latest news to stay up to date with the company, its products, solutions and services.

News

Great North Research Conference

QMDx attended the Great North Research Conference recently. This was the first conference organised by NIHR to bring together academics and commercial companies within the North of England, to celebrate their achievements and showcase their expertise to allow for collaboration…

News

A convention space with many people sitting on chairs attending a presentation

Transforming Point-of-Care Molecular Diagnostics at GIS23 Summit

We are delighted to share another achievement for QuantuMDx, and the North-East, within the molecular…

News

Man giving a QuatuMDx presentation on a big screen

QuantuMDx presents at The Union World Conference on Lung Health 2023

QuantuMDx presents at The Union World Conference on Lung Health 2023 QuantuMDx recently presented at…

Media Alert

QuantuMDx receives CTDA approval for sale of Q-POC™

NEWCASTLE UPON TYNE, UK 13 December, 2022. QuantuMDx Group Limited (“QuantuMDx”), today announces that its Q-POC™ SARS-CoV-2, Flu A/B & RSV Assay, has been approved for sale in the UK under The Medical Devices (Coronavirus Test Device Approvals) (Amendment) Regulations…

Previous Next

CAPTURE-XT explained

Sample cleanup and pathogen concentration

Future development

A novel microfluidic lab-on-a-chip sample clean up and cell concentration technology. Available as a prototype.

Close up of tubercolosis under microscope

Tuberculosis - the challenge

RISK6 explained

Simplified Workflow

Future development

A multiplex PCR laboratory assay to detect host-response-mediated mRNA transcripts present in whole blood. For Research Use Only.

A supercharged platform, with a fast workflow

A smooth user experience with an intuitive interface

A ready to use solution, with all its simplicity, accuracy and speed

A ton of tech behind every result, with intelligent multilingual software algorithms.

A huge leap in rapid multiplex PCR testing, with a small, portable, battery-operated system

A rapid multiplex PCR testing system that delivers results in approximately thirty minutes at the Point of Care.

High quality multiplex PCR testing, as simple as a lateral flow test

A sustainable respiratory infection control solution with the quality of lab-based PCR testing

Results you can trust, with a simple procedure and reliable testing

Meet the challenges of the Winter Season with a respiratory infection test designed to deliver rapid PCR results on demand, in 35 minutes, at the Point of Care.

News & Events

Great North Research Conference

Transforming Point-of-Care Molecular Diagnostics at GIS23 Summit

QuantuMDx presents at The Union World Conference on Lung Health 2023

QuantuMDx receives CTDA approval for sale of Q-POC™

CAPTURE-XT

TB Host Immune Response Assay (TB-HIRA)

Q-POC Platform

Respiratory Solution